Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14980
Full Text
Open PDFAbstract
Available in full text
Date
October 14, 2018
Authors
Publisher
Wiley